Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations - sprookjes - yvandenbroek - TriplyDB

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

http://www.wikidata.org/entity/Q22241134

about

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Sulphonylurea monotherapy for patients with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning Standards of medical care in diabetes--2012 Clinically and pharmacologically relevant interactions of antidiabetic drugs Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies Diabetic kidney disease: from physiology to therapeutics Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease Avoiding weight gain in cardiometabolic disease: a systematic review Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes Standards of medical care in diabetes--2013 Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme.Precision diabetes: learning from monogenic diabetes.Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: A meta-analysis.B lymphocytes in human subcutaneous adipose crown-like structures Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data Emerging gliptins for type 2 diabetes.Drug-drug interactions with sodium-glucose cotransporters type 2 (SGLT2) inhibitors, new oral glucose-lowering agents for the management of type 2 diabetes mellitus.Results from a dietary survey in an Indian T2DM population: a STARCH study.Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia.Personalizing guidelines for diabetes management: twilight or dawn of the expert?Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis

P2860

Q21144611-64EBE71E-56B1-4F32-A0B2-0C63BC0E2B32 Q22241288-51AA2683-98EC-4F95-9A6C-7E63AD163F35 Q24186660-0C8C6327-F3A4-425A-913F-F583231F15D0 Q24197884-26B5387D-69D5-4328-81EF-A9EA2E56371E Q24604853-8D4A5BFF-901E-4EE9-A6F4-D46091EC9F59 Q24632533-4CCED567-4A2B-47AA-9CCF-CEAEB19A6B42 Q26752468-DBF354E8-07D8-4AFC-A32B-61E5E69625ED Q26767283-F137E704-FE13-4C28-81A5-707022A8C67B Q26999933-4C552FB2-82FA-4B64-8DA6-AA562E029D4F Q27021392-3D5C95CA-5692-4593-8AFA-E208388E1AC0 Q27026847-A425FBEF-17AD-41F4-982A-BBF78BCC8958 Q27301757-69B2C0FA-8695-47F6-BFD5-1CA123D8A71C Q27687851-F049756A-0481-4A79-8A63-CAAC21FE0050 Q28069065-0006D1E6-CA5F-4400-98BD-95228C9C422F Q28081926-6AE4C694-BFF2-44E0-8F21-7458D9A1E94B Q28481010-AF60DA91-CBB5-4FAA-8CED-FADAAF2BF121 Q28547140-89DB40DD-4F65-4FEF-A3AA-0B9C2BB78B8B Q28732681-1466D2D9-0EAC-4E01-A951-BD12410E8F17 Q29620309-B7565C17-633D-4266-A7D5-724AEEB30845 Q29994589-02328BF4-9C3D-4763-81D1-39FC5730FEF5 Q30239808-5AD416FF-F591-46D2-850F-E8B521BDBAD9 Q31130301-987DEC2B-4F17-40F8-9241-7236E0DA97EE Q33453490-BFB2ADEA-399D-40B0-A05C-E53804A9190B Q33556240-BBE6E8C5-C32D-4099-ADEC-DE9400B8D25C Q33696974-C9042B86-3608-4E8F-82B0-BABA45FECC0F Q33812170-5F11FB99-DC33-4F25-8845-55FA4C07A2D7 Q33858377-FC066D8D-5692-499E-BEBF-1EDDDAF36EC7 Q33871397-B70F578A-047F-4C56-8C4F-0A02BE754602 Q34186722-264F2A58-831C-4686-94DB-0BE19C5814FD Q34286013-FD420E31-1050-42F2-B27A-AAFACBBF1AED Q34347884-B0412EF7-9F5F-4369-BE2F-E3BDB68AFA9C Q34397646-AA4CDCD9-587C-4066-B483-CD720376C2A6 Q34439045-E06827CA-7E63-4130-A95C-18B64F0CB777 Q34454269-FF5F7E9E-DBC8-4F8A-A9D1-8B8260E67F8A Q34644993-FDEA5412-E39D-4BBC-84F5-2346A6017B63 Q34646948-1EF5C3D3-4818-422C-99E7-508F9A34F842 Q34725461-29958997-E304-4546-9522-F24736C28F9A Q34810165-9428EE0B-539A-4DF8-AD08-F93B419AFE21 Q35042504-005074F9-05D5-4DBF-AFC8-44D38DEB6533 Q35114963-62E65769-817F-43DA-A810-F53571918478

P2860

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

http://www.wikidata.org/entity/Q22241134

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comparative effectiveness and ...... drugs and 2-drug combinations

@ast

Comparative effectiveness and ...... drugs and 2-drug combinations

@en

Comparative effectiveness and ...... drugs and 2-drug combinations

@en-gb

Comparative effectiveness and ...... drugs and 2-drug combinations

@nl

type

label

Comparative effectiveness and ...... drugs and 2-drug combinations

@ast

Comparative effectiveness and ...... drugs and 2-drug combinations

@en

Comparative effectiveness and ...... drugs and 2-drug combinations

@en-gb

Comparative effectiveness and ...... drugs and 2-drug combinations

@nl

prefLabel

Comparative effectiveness and ...... drugs and 2-drug combinations

@ast

Comparative effectiveness and ...... drugs and 2-drug combinations

@en

Comparative effectiveness and ...... drugs and 2-drug combinations

@en-gb

Comparative effectiveness and ...... drugs and 2-drug combinations

@nl

P1433

Q22241134-F4519F3D-7D1E-4F69-B369-25BA448598F6

P1476

Q22241134-05249BF7-22A2-49D0-819D-EAC788511973

P2093

Q22241134-00FFC96C-041D-437D-9D4A-8474CFF4DD94

Q22241134-165FEF73-6ADF-478B-8201-20F009835382

Q22241134-1984061D-D91F-47C3-9F24-C1FD14BBC7F9

Q22241134-31591AC5-076C-4344-8B7F-34DDA404B1D6

Q22241134-4AE55A2B-EA10-4E42-AB30-C81E449E517A

Q22241134-5A5A5D8C-EFBA-424C-A3A3-38C9EB0C26A7

Q22241134-6BF6CB29-40FA-4104-9F2D-F62F41064611

Q22241134-883292DE-1EE7-41E0-89A7-5AE1605E4F0A

Q22241134-940C0A37-3D56-4FF7-8E91-D080F5130F95

Q22241134-A5B84068-1FD1-47A7-ADF3-538B568354DA

P2860

Q22241134-05AD99BB-69DF-42DB-B41C-A6FFE821674B

Q22241134-05D25AB5-5F5B-4289-A818-ADB6A8B27582

Q22241134-0696FE99-6379-4DC6-8BB1-2DA8D4D3FFDF

Q22241134-0A145253-2CBE-4B78-84CF-8B2177C3E06C

Q22241134-1006EBAF-DA40-472C-ADB0-EC1FF7F87BEF

Q22241134-10D348AE-9A1D-446C-B338-45C69AB6C53A

Q22241134-27583045-D5BE-405B-883C-59C74734B098

Q22241134-2D5D9B01-755A-4FFE-94F4-51E271F39948

Q22241134-2E8BB9A5-CAF4-4133-B16B-3F952B79EA58

Q22241134-34FBC8FC-10C7-47A5-B3B9-604998768017

P304

Q22241134-80714F85-015C-4EFD-A662-3278B29F2AAB

P31

Q22241134-AA006BB7-B382-4078-8D5A-3C26BDB10D52

P3181

Q22241134-0112AFDC-64CF-4748-B3EC-05239218527B

P356

Q22241134-CF76AB2B-1073-45B4-B540-F1402687CE5E

P407

Q22241134-E81F18CA-3F20-4F3E-B21D-B7A5473CE01A

P433

Q22241134-D780C2CC-66AD-4F3A-8A60-D02232E3D87D

P478

Q22241134-DD7FB927-4B80-4CDD-AACA-D6A25D3A35C7

P577

Q22241134-29999EC5-4869-4381-A93E-F39911E72632

P698

Q22241134-5AB2DDAE-B513-41A8-9308-A68628A8CE27

P921

Q22241134-96C146E8-F687-4233-94AB-EFD38445DA48

P932

Q22241134-2CE93E2A-B044-48F8-8038-B5412EA9802E

P3181

P356

0003-4819-154-9-201105030-00336

P1433

Annals of Internal Medicine

P1476

Comparative effectiveness and ...... drugs and 2-drug combinations

@en

P2093

Eric B Bass

http://www.w3.org/2001/XMLSchema#string

Jodi B Segal

http://www.w3.org/2001/XMLSchema#string

Lauren Block

http://www.w3.org/2001/XMLSchema#string

Lisa M Wilson

http://www.w3.org/2001/XMLSchema#string

Milo A Puhan

http://www.w3.org/2001/XMLSchema#string

Nisa M Maruthur

http://www.w3.org/2001/XMLSchema#string

Padmini Ranasinghe

http://www.w3.org/2001/XMLSchema#string

Ranee Chatterjee

http://www.w3.org/2001/XMLSchema#string

Shari Bolen

http://www.w3.org/2001/XMLSchema#string

Sonal Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

Rosiglitazone for type 2 diabetes mellitus

Meglitinide analogues for type 2 diabetes mellitus

National trends in treatment of type 2 diabetes mellitus, 1994-2007

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Bias in meta-analysis detected by a simple, graphical test

Operating characteristics of a rank correlation test for publication bias

P304

602-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1077797

http://www.w3.org/2001/XMLSchema#string

P356

10.7326/0003-4819-154-9-201105030-00336

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21403054

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3733115

http://www.w3.org/2001/XMLSchema#string